MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
48.74
+2.86
+6.23%
After Hours: 49.00 +0.26 +0.53% 19:57 02/06 EST
OPEN
47.22
PREV CLOSE
45.88
HIGH
48.99
LOW
46.27
VOLUME
1.67M
TURNOVER
--
52 WEEK HIGH
78.48
52 WEEK LOW
30.04
MARKET CAP
4.64B
P/E (TTM)
-8.7348
1D
5D
1M
3M
1Y
5Y
1D
ARKK, CRSP, ROKU, TEM: Large Outflows Detected at ETF
NASDAQ · 1d ago
Cathie Wood's weekly recap: ramps up bets on JOBY, CRSP, pares ILMN, VCYT
Seeking Alpha · 4d ago
Weekly Report: what happened at CRSP last week (0126-0130)?
Weekly Report · 4d ago
IBM, P&G, GameStop, Crispr, AGNC: Insider Moves Exposed
TipRanks · 6d ago
Crispr Therapeutics Is Maintained at Market Outperform by Citizens
Dow Jones · 01/30 14:25
Crispr Therapeutics Price Target Cut to $80.00/Share From $86.00 by Citizens
Dow Jones · 01/30 14:25
Citizens Maintains Market Outperform on CRISPR Therapeutics, Lowers Price Target to $80
Benzinga · 01/30 14:15
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
NASDAQ · 01/30 13:07
More
About CRSP
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.